Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection
出版年份 2020 全文链接
标题
Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection
作者
关键词
-
出版物
JOURNAL OF GASTROENTEROLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-11-19
DOI
10.1007/s00535-020-01750-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B
- (2020) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- No difference in hepatocellular carcinoma risk between chronic hepatitis B patients treated with entecavir versus tenofovir
- (2020) Feng Su et al. GUT
- Comparative Effectiveness of Entecavir vs Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: a Systematic Review and Meta-analysis
- (2020) Shravan Dave et al. HEPATOLOGY
- An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia
- (2020) Michael R. Charlton et al. JOURNAL OF GASTROENTEROLOGY
- Effects of resistance‐associated variants in genotype 2 hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs
- (2019) Goki Suda et al. HEPATOLOGY RESEARCH
- Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis
- (2019) Kazuharu Suzuki et al. HEPATOLOGY RESEARCH
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction
- (2018) Takuya Sho et al. HEPATOLOGY RESEARCH
- Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection
- (2018) Goki Suda et al. JOURNAL OF GASTROENTEROLOGY
- Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment
- (2018) Grace Lai-Hung Wong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
- (2018) Makoto Kinoshita et al. Journal of Atherosclerosis and Thrombosis
- Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice
- (2018) Xuchu Que et al. NATURE
- Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B
- (2018) Jonggi Choi et al. JAMA Oncology
- PAPD5/7 are novel host factors that are required for Hepatitis B virus RNA stabilization
- (2018) Henrik Mueller et al. HEPATOLOGY
- Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment
- (2017) Goki Suda et al. HEPATOLOGY RESEARCH
- Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan
- (2017) Goki Suda et al. JOURNAL OF GASTROENTEROLOGY
- Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy
- (2017) Goki Suda et al. JOURNAL OF GASTROENTEROLOGY
- Hepatitis B virus reactivation during hepatitis C direct-acting antiviral therapy in patients with previous HBV infection
- (2017) Naoki Kawagishi et al. JOURNAL OF HEPATOLOGY
- Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis
- (2017) Yasushi Honda et al. Scientific Reports
- Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection
- (2016) Kazumoto Murata et al. GUT
- Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C
- (2016) Goki Suda et al. JOURNAL OF GASTROENTEROLOGY
- Anti-adipogenic and antiviral effects ofl-carnitine on hepatitis C virus infection
- (2016) Yoko Tsukuda et al. JOURNAL OF MEDICAL VIROLOGY
- Hepatitis B virus X protein impairs α-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A
- (2016) Seiji Tsunematsu et al. JOURNAL OF MEDICAL VIROLOGY
- Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance
- (2016) Wojciech G. Garbacz et al. MOLECULAR AND CELLULAR BIOLOGY
- The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial
- (2015) José R. Santos et al. CLINICAL INFECTIOUS DISEASES
- JSH Guidelines for the Management of Hepatitis B Virus Infection
- (2014) HEPATOLOGY RESEARCH
- Hepatitis B virus infection
- (2014) Christian Trépo et al. LANCET
- Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C
- (2011) Scott R Walter et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells
- (2011) May Brundert et al. JOURNAL OF LIPID RESEARCH
- Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima–media thickness
- (2010) Joseph AC Delaney et al. AIDS
- Peroxisome Proliferator-Activated Receptor Alpha Target Genes
- (2010) Maryam Rakhshandehroo et al. PPAR Research
- Circulating oxidized LDL: a biomarker and a pathogenic factor
- (2009) Yasushi Ishigaki et al. CURRENT OPINION IN LIPIDOLOGY
- CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
- (2009) R. L. Silverstein et al. Science Signaling
- Mouse CD36 Has Opposite Effects on LDL and Oxidized LDL Metabolism In Vivo
- (2008) Vilayphone Luangrath et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Impact of Plasma Oxidized Low-Density Lipoprotein Removal on Atherosclerosis
- (2008) Yasushi Ishigaki et al. CIRCULATION
- Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis
- (2007) Jie Zhou et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search